Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by N0taP00p


V.TLT

RE:RE:Here we go again

@Budfoxx: FWIW, you're the exact opposite of SF and co.  In both...

October 23, 2023

V.TLT

Here we go again

A jumbled up NR that is open to interpretation wrt timelines for BTD...

October 23, 2023

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:RE:New Press Release - Theralase(R) Provides Update on Bladder Cancer Clinical Study

@999: Unless people are a bit dense, it is easy to see that the "fear...

October 16, 2023

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:New Press Release - Theralase(R) Provides Update on Bladder Cancer Clinical Study

@consultant99: Been wondering the same. I think it might be the hangover from...

October 16, 2023

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:New Press Release - Theralase(R) Provides Update on Bladder Cancer Clinical Study

Feels like an NR that did not tell us  substantially more than we...

October 16, 2023

V.TLT

RE:TPST, a harbinger for TLT?

Saw that today. Wow.  Why not TLT if results are good and they get BTD...

October 11, 2023

V.TLT

RE:It's all coming together...

We get the intent and like it. But "coming soon" is subject to a...

October 10, 2023

V.TLT

RE:BTD and pre-BTD overview

According to the details from 8 years ago, pre-BTD seems to be a 15 minute...

October 9, 2023

V.TLT

BTD and pre-BTD overview

While we wait, a useful link with additional YouTube links to detailed...

October 9, 2023

V.TLT

FDA programs to accelerate development

Very good overview at link below. For all practical purposes,  Ruvidar...

October 4, 2023

V.TLT

RE:sigh

I've bought a few thousand here and  there during these unexplained...

October 2, 2023

V.TLT

RE:RE:RE:GBM

Thank you, DJDawg.  Good perspective .Well, from today's NR, we know...

September 29, 2023

V.TLT

RE:GBM

DJDawg:  What's your estimate of timeline for GBM?  Non-GLP and...

September 28, 2023

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Financial Advisor

@GrahamB:  After nearly two years of working with the FDA as a fast...

September 26, 2023

V.TLT

RE:RE:RE:Financial Advisor

CAinPlap: I was thinking about the FDAs Frontrunner program where a promising...

September 20, 2023

V.TLT

RE:Financial Advisor

I think we can all relate to that feeling, Camp. Sometimes, we invest based...

September 20, 2023

V.TLT

RE:Bored. Waiting. Here is some playing with data to look at.

@DJDawg:  Now that is what I call really good work!! Your summary table...

September 19, 2023

V.TLT

RE:RE:RE:Patent Update - Final Rejection (again)

Pandora. Wow. Thank you. You're more than a messenger. That was a mini...

September 19, 2023

V.TLT

RE:Patent Update - Final Rejection (again)

Pandora: What is your assessment of these rejections?  Big deal? No big...

September 19, 2023

V.TLT

RE:RE:RE:RE:Keytruda story

@999: SF, the recipient of abusive posts?  Cry me a river. Shouldn't...

September 15, 2023

Featured Company